203 related articles for article (PubMed ID: 11101087)
1. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
[No Abstract] [Full Text] [Related]
2. Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Pellegrin I; Segondy M; Garrigue I; Izopet J; Montes B; Pellegrin JL; Reynes J; Massip P; Puel J; Fleury H
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):465-6. PubMed ID: 11141248
[No Abstract] [Full Text] [Related]
3. Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine.
Milazzo L; Rusconi S; Testa L; La Seta-Catamancio S; Galazzi M; Kurtagic S; Citterio P; Gianotto M; Grassini A; Adorni F; d'Arminio-Monforte A; Galli M; Moroni M
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):101-3. PubMed ID: 10534153
[No Abstract] [Full Text] [Related]
4. Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen.
Pellegrin I; Garrigue I; Caumont A; Pellegrin JL; Merel P; Schrive MH; Bonot P; Fleury H
AIDS; 2001 May; 15(8):1071-3. PubMed ID: 11399996
[No Abstract] [Full Text] [Related]
5. R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.
Torti C; Gilleece Y; Hertogs K; Gazzard BG; Pozniak AL
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):514-5. PubMed ID: 11391177
[No Abstract] [Full Text] [Related]
6. Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy.
Batisse D; Karmochkine M; Si Mohamed A; Piketty C; Kazatchkine MD; Belec L
AIDS; 1998 May; 12(7):824-5. PubMed ID: 9619820
[No Abstract] [Full Text] [Related]
7. Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
Ross L; Scarsella A; Raffanti S; Henry K; Becker S; Fisher R; Liao Q; Hirani A; Graham N; St Clair M; Hernandez J;
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1107-15. PubMed ID: 11522180
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
Vanhems P; Gaudet R; Hirschel B; Imrie A; Conway B; Rouleau D; Vizzard J; Perrin L; Cooper DA; Yerly S
AIDS; 2000 May; 14(8):1065-7. PubMed ID: 10853993
[No Abstract] [Full Text] [Related]
9. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.
Ross L; Henry K; Paar D; Salvato P; Shaefer M; Fisher R; Liao Q; St Clair M
J Hum Virol; 2001; 4(4):217-22. PubMed ID: 11694850
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.
Lafeuillade A; Poggi C; Hittinger G; Chadapaud S
HIV Med; 2001 Oct; 2(4):231-5. PubMed ID: 11737402
[TBL] [Abstract][Full Text] [Related]
11. A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
Kuritzkes DR
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13485-7. PubMed ID: 11717419
[No Abstract] [Full Text] [Related]
12. Transmission of zidovudine resistant strains of HIV-1: the first wave.
Blower S
AIDS; 2001 Nov; 15(17):2317-8. PubMed ID: 11698706
[No Abstract] [Full Text] [Related]
13. Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Shulman NS; Hughes MD; Winters MA; Shafer RW; Zolopa AR; Hellmann NS; Bates M; Whitcomb JM; Katzenstein DA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):121-7. PubMed ID: 12394789
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
Montaner JS; Mo T; Raboud JM; Rae S; Alexander CS; Zala C; Rouleau D; Harrigan PR
J Infect Dis; 2000 Feb; 181(2):729-32. PubMed ID: 10669364
[TBL] [Abstract][Full Text] [Related]
15. M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine.
Ait-Khaled M; Stone C; Amphlett G; Clotet B; Staszewski S; Katlama C; Tisdale M;
AIDS; 2002 Aug; 16(12):1686-9. PubMed ID: 12172093
[TBL] [Abstract][Full Text] [Related]
16. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
Picard V; Angelini E; Maillard A; Race E; Clavel F; Chêne G; Ferchal F; Molina JM
J Infect Dis; 2001 Sep; 184(6):781-4. PubMed ID: 11517441
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
[TBL] [Abstract][Full Text] [Related]
19. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
Lukashov VV; Huismans R; Jebbink MF; Danner SA; de Boer RJ; Goudsmit J
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):807-18. PubMed ID: 11429122
[TBL] [Abstract][Full Text] [Related]
20. Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.
Shulman NS; Machekano RA; Shafer RW; Winters MA; Zolopa AR; Liou SH; Hughes M; Katzenstein DA;
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):377-80. PubMed ID: 11468426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
